Cardio Diagnostics Holdings, Inc. (CDIO)
1.76
+0.09
(+5.39%)
USD |
NASDAQ |
Oct 15, 16:00
1.77
+0.01
(+0.57%)
After-Hours: 04:10
Cardio Diagnostics Holdings Cash from Operations (TTM) : -5.660M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.660M |
| March 31, 2026 | -5.889M |
| December 31, 2025 | -5.727M |
| September 30, 2025 | -5.757M |
| June 30, 2025 | -5.521M |
| March 31, 2025 | -5.160M |
| December 31, 2024 | -4.993M |
| September 30, 2024 | -5.286M |
| June 30, 2024 | -5.174M |
| Date | Value |
|---|---|
| March 31, 2024 | -5.256M |
| December 31, 2023 | -5.672M |
| September 30, 2023 | -7.107M |
| June 30, 2023 | -7.452M |
| March 31, 2023 | -6.554M |
| December 31, 2022 | -5.091M |
| September 30, 2022 | -2.556M |
| June 30, 2022 | -1.130M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Tenax Therapeutics, Inc. | -46.03M |
| Exicure, Inc. | -6.704M |
| Century Therapeutics, Inc. | -86.74M |
| Absci Corp. | -108.08M |
| Celularity, Inc. | -8.814M |